We are a clinical-stage biotech company pioneering first-in-class treatments to revolutionize metabolic health. Our mission is to redefine the management of diabetes, obesity, and other metabolic diseases, by harnessing the potential of small molecules with distinct and novel signaling profiles.
| Website | http://www.atrogi.com |
| Revenue | $3 million |
| Employees | 21 (10 on RocketReach) |
| Phone | +46 70 471 12 61 |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Biotechnology, Clinical Stage, Drug Development, Metabolic Diseases, Drug Discovery, Pharmaceutical, Biopharma, Diabetes Treatment, Obesity Treatment, Clinical Trials, Small Molecule Drugs, Novel Therapies, Innovation, Research, New Treatments, Healthcare, Medicine, Health, Medical Research |
| Competitors | Microsoft, Airtable, Zapier, Workato, Parabola, Tray.io, Pipedream, IFTTT, Integromat, Automate.io (acquired by Notion) +46 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Atrogi employee's phone or email?
The Atrogi annual revenue was $3 million in 2026.
Alexandra Ryding is the CEO of Atrogi.
10 people are employed at Atrogi.
Atrogi is based in Stockholm, Stockholm County.
The NAICS codes for Atrogi are [32541, 325, 3254, 32].
The SIC codes for Atrogi are [283, 28].